company background image
PHX logo

PharmX Technologies CHIA:PHX Stock Report

Last Price

AU$0.075

Market Cap

AU$44.9m

7D

-1.3%

1Y

141.9%

Updated

10 May, 2025

Data

Company Financials

PharmX Technologies Limited

CHIA:PHX Stock Report

Market Cap: AU$44.9m

PHX Stock Overview

Operates as a technology and software development company in Australia. More details

PHX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

PharmX Technologies Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for PharmX Technologies
Historical stock prices
Current Share PriceAU$0.075
52 Week HighAU$0.086
52 Week LowAU$0.027
Beta0.88
1 Month Change2.74%
3 Month Change-7.41%
1 Year Change141.94%
3 Year Change59.57%
5 Year Change87.50%
Change since IPO-31.82%

Recent News & Updates

Recent updates

Shareholder Returns

PHXAU SoftwareAU Market
7D-1.3%1.3%0.05%
1Y141.9%21.1%4.3%

Return vs Industry: PHX exceeded the Australian Software industry which returned 21.1% over the past year.

Return vs Market: PHX exceeded the Australian Market which returned 4.3% over the past year.

Price Volatility

Is PHX's price volatile compared to industry and market?
PHX volatility
PHX Average Weekly Movement7.7%
Software Industry Average Movement9.0%
Market Average Movement9.3%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market4.2%

Stable Share Price: PHX has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: PHX's weekly volatility has decreased from 16% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1950n/aTom Culverpharmx.com.au

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023.

PharmX Technologies Limited Fundamentals Summary

How do PharmX Technologies's earnings and revenue compare to its market cap?
PHX fundamental statistics
Market capAU$44.89m
Earnings (TTM)AU$14.00k
Revenue (TTM)AU$8.63m

3,206x

P/E Ratio

5.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHX income statement (TTM)
RevenueAU$8.63m
Cost of RevenueAU$4.67m
Gross ProfitAU$3.97m
Other ExpensesAU$3.95m
EarningsAU$14.00k

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.000023
Gross Margin45.93%
Net Profit Margin0.16%
Debt/Equity Ratio0%

How did PHX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 02:11
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PharmX Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.